Differential modulation of cyclin gene expression by MYC - PubMed (original) (raw)
Differential modulation of cyclin gene expression by MYC
P Jansen-Dürr et al. Proc Natl Acad Sci U S A. 1993.
Abstract
We have investigated the effects of deregulated expression of the human c-MYC protooncogene on cyclin gene expression and on the transcription factor E2F. We found that constitutive expression of MYC or activation of conditional MycER chimeras led to higher levels of cyclin A and cyclin E mRNA. Activation of cyclin A expression by MYC led to a growth factor-independent association of cyclin A and cdk2 with the transcription factor E2F and correlated with an increase in E2F transcriptional activity. In contrast, expression of the G1 phase cyclin D1 was strongly reduced in MYC-transformed cells. In synchronized cells, repression of cyclin D1 by MYC occurred very early in the G1 phase of the cell cycle.
Similar articles
- Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D, Schulze A, Boye B, Jansen-Dürr P. Spitkovsky D, et al. Cell Growth Differ. 1997 Jun;8(6):699-710. Cell Growth Differ. 1997. PMID: 9186003 - c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG, Moses HL. Alexandrow MG, et al. J Cell Biochem. 1998 Sep 15;70(4):528-42. J Cell Biochem. 1998. PMID: 9712150 - Cell-cycle regulation of gene expression by transcriptional repression.
Zwicker J, Müller R. Zwicker J, et al. Trends Genet. 1997 Jan;13(1):3-6. doi: 10.1016/s0168-9525(96)30112-1. Trends Genet. 1997. PMID: 9009839 Review. No abstract available. - Identification of target genes of oncogenic transcription factors.
Boyd KE, Farnham PJ. Boyd KE, et al. Proc Soc Exp Biol Med. 1999 Oct;222(1):9-28. doi: 10.1111/j.1525-1373.1999.09992.x. Proc Soc Exp Biol Med. 1999. PMID: 10510243 Review.
Cited by
- Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.
Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, Mischak H, Stevens LM, Henderson DW, Mushinski JF. Mai S, et al. Neoplasia. 1999 Aug;1(3):241-52. doi: 10.1038/sj.neo.7900030. Neoplasia. 1999. PMID: 10935479 Free PMC article. - Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.
Lewis BC, Shim H, Li Q, Wu CS, Lee LA, Maity A, Dang CV. Lewis BC, et al. Mol Cell Biol. 1997 Sep;17(9):4967-78. doi: 10.1128/MCB.17.9.4967. Mol Cell Biol. 1997. PMID: 9271375 Free PMC article. - Signaling by ABL oncogenes through cyclin D1.
Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF. Afar DE, et al. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9540-4. doi: 10.1073/pnas.92.21.9540. Proc Natl Acad Sci U S A. 1995. PMID: 7568169 Free PMC article. - Role of protein kinase activity in apoptosis.
Lavin MF, Watters D, Song Q. Lavin MF, et al. Experientia. 1996 Oct 31;52(10-11):979-94. doi: 10.1007/BF01920107. Experientia. 1996. PMID: 8917729 Review. - Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.
Rodríguez JL, Sandoval J, Serviddio G, Sastre J, Morante M, Perrelli MG, Martínez-Chantar ML, Viña J, Viña JR, Mato JM, Avila MA, Franco L, López-Rodas G, Torres L. Rodríguez JL, et al. Biochem J. 2006 Sep 15;398(3):431-7. doi: 10.1042/BJ20060380. Biochem J. 2006. PMID: 16776654 Free PMC article.
References
- Cell. 1978 Apr;13(4):751-60 - PubMed
- EMBO J. 1989 Nov;8(11):3365-70 - PubMed
- Nucleic Acids Res. 1985 Mar 11;13(5):1431-42 - PubMed
- Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
- J Virol. 1988 May;62(5):1814-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials